Clinical Trial Update: Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut

View source ↗

Summary

Expanded access/compassionate use protocol for rindopepimut in recurrent glioblastoma has ended or is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Rindopepimut (rindopepimut)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Recurrent GBM | Status: NO_LONGER_AVAILABLE